Skip to main content

Want a detailed portfolio tracker?

CASI Pharmaceuticals (CASI) Income Statement (2020 - 2025)

Annual Income Statement report data from Dec 31, 2020 to Dec 31, 2025 for CASI Pharmaceuticals (CASI).

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Reported currency: USD
202520242023202220212020
Revenue and COGS
Total Revenue
21M
(-27.44%)
29M
(-15.76%)
34M
(-10.96%)
38M
(+26.75%)
30M
(+100.13%)
15M
Gross Profit
10M
(-9.60%)
11M
(-44.39%)
20M
(-26.50%)
27M
(+54.91%)
18M
(+212.79%)
5.63M
Operating Expenses
Research And Development
6.31M
(-29.26%)
8.92M
(-9.53%)
9.86M
(-38.38%)
16M
(+10.96%)
14M
(+25.72%)
11M
Selling General And Administrative
28M
(+19.89%)
24M
(-7.13%)
25M
(+8.27%)
23M
(-1.05%)
24M
(+20.55%)
20M
Operating Expenses
55M
(+8.49%)
51M
(+12.50%)
45M
(-26.39%)
61M
(+3.69%)
59M
(+1.23%)
58M
Depreciation And Amortization
1.20M
(-7.69%)
1.30M
(-48.00%)
2.50M
(+108.33%)
1.20M
(+140.00%)
500K
(-16.67%)
600K
Operating Income
Operating Income
-45.01M
(+13.60%)
-39.62M
(+57.97%)
-25.08M
(-26.30%)
-34.03M
(-18.04%)
-41.52M
(-21.33%)
-52.78M
Ebit
-45.01M
(+13.60%)
-39.62M
(+57.97%)
-25.08M
(-26.30%)
-34.03M
(-18.04%)
-41.52M
(-21.33%)
-52.78M
EBITDA
-43.81M
(+14.33%)
-38.32M
(+69.71%)
-22.58M
(-31.22%)
-32.83M
(-19.97%)
-41.02M
(-21.39%)
-52.18M
Other Income / Expenses
Other Non Operating Income
20K
(-89.47%)
190K
(-75.00%)
760K
(+1800.00%)
40K
(-92.86%)
560K
(+600.00%)
80K
Net Income
Income Tax Expense
---80.00K1.98M--
Net Income From Continuing Operations
-48.06M
(+22.41%)
-39.26M
(+45.62%)
-26.96M
(-34.26%)
-41.01M
(+11.90%)
-36.65M
(-24.10%)
-48.29M
Net Income
-48.06M
(+22.41%)
-39.26M
(+45.62%)
-26.96M
(-34.26%)
-41.01M
(+11.90%)
-36.65M
(-24.10%)
-48.29M
Comprehensive Income Net Of Tax
-48.07M
(+20.69%)
-39.83M
(+64.93%)
-24.15M
(-29.32%)
-34.17M
(+1.15%)
-33.78M
(-21.95%)
-43.28M